CoChat

Depression treatment response to ketamine: sex-specific role of interleukin-8, but not other inflammatory markers

Open access

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Inflammation plays a role in depression pathophysiology and treatment response, with effects varying by sex and therapeutic modality. Lower levels of interleukin(IL)-8 predict depression response to antidepressant medication and to electroconvulsive therapy (ECT), although ECT effects are specific to females. Whether IL-8 predicts depression response to ketamine and in a sex-specific manner is not known. Here, depressed patients (n = 46; female, n = 17) received open label infusion of ketamine (0.5 mg/kg over 40 min; NCT02165449). Plasma levels of IL-8 were evaluated at baseline and post-treatment. Baseline levels of IL-8 had a trending association with response to ketamine, depending upon sex (responder status × sex interaction: p = 0.096), in which lower baseline levels of IL-8 in females (p = 0.095) but not males (p = 0.96) trended with treatment response. Change in levels of IL-8 from baseline to post-treatment differed significantly by responder status (defined as ≥50% reduction in Hamilton Depression Rating Scale [HAM-D] Score), depending upon sex (responder status × sex × time interaction: F(1,42)=6.68, p = 0.01). In addition, change in IL-8 interacted with sex to predict change in HAM-D score (β = -0.63, p = 0.003); increasing IL-8 was associated with decreasing HAM-D score in females (p = 0.08) whereas the inverse was found in males (p = 0.02). Other inflammatory markers (IL-6, IL-10, tumor necrosis factor-α, C-reactive protein) were explored with no significant relationships identified. Given these preliminary findings, further evaluation of sex differences in the relationship between IL-8 and treatment response is warranted to elucidate mechanisms of response and aid in the development of personalized approaches to depression treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-021-01268-z

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Interleukin-8 at baseline and post-treatment in responders versus non-responders, stratified by sex. Levels of IL-8 at baseline and post-treatment (approximately 24 h following ketamine infusion) are shown in female (A, n = 17) and male (B, n = 29) subjects, stratified by non-responders (blue boxes) and responders (red boxes). Baseline levels of IL-8 varied in relation to responder status and sex (responder status × sex interaction: β = −0.36, p = 0.096). Females, but not males, showed a statistical trend between lower baseline IL-8 levels and depression response to ketamine (females: p = 0.095, effect size (sr2) = 0.16; males: p = 0.96, effect size (sr2) <0.01). Change in levels of IL-8 from baseline to post-treatment varied in relation to responder status and sex (responder status × sex × time interaction): F(1,42)=6.68, p = 0.01.
Fig. 1 Interleukin-8 at baseline and post-treatment in responders versus non-responders, stratified by sex. Levels of IL-8 at baseline and post-treatment (approximately 24 h following ketamine infusion) are shown in female (A, n = 17) and male (B, n = 29) subjects, stratified by non-responders (blue boxes) and responders (red boxes). Baseline levels of IL-8 varied in relation to responder status and sex (responder status × sex interaction: β = −0.36, p = 0.096). Females, but not males, showed a statistical trend between lower baseline IL-8 levels and depression response to ketamine (females: p = 0.095, effect size (sr2) = 0.16; males: p = 0.96, effect size (sr2) <0.01). Change in levels of IL-8 from baseline to post-treatment varied in relation to responder status and sex (responder status × sex × time interaction): F(1,42)=6.68, p = 0.01.CC BY · PubMed Central
Fig. 2 Interleukin-8 change from baseline to post-treatment associates with HAM-D percentage change, depending upon sex. Effect sizes (sr2) and p values are shown from linear regression analyses of the relationship between the change in IL-8 (post-treatment [approximately 24 h following ketamine infusion] minus baseline) and the percentage change in HAM-D score, in females (A) and in males (B). Change in IL-8 was calculated and plotted utilizing base-10 log-transformed data, but the x-axis is labeled with non-transformed values (pg/mL) for ease of interpretation. Change in IL-8 interacted with sex to predict change in HAM-D score (β = −0.63, p = 0.003). All analyses included age and BMI as covariates.
Fig. 2 Interleukin-8 change from baseline to post-treatment associates with HAM-D percentage change, depending upon sex. Effect sizes (sr2) and p values are shown from linear regression analyses of the relationship between the change in IL-8 (post-treatment [approximately 24 h following ketamine infusion] minus baseline) and the percentage change in HAM-D score, in females (A) and in males (B). Change in IL-8 was calculated and plotted utilizing base-10 log-transformed data, but the x-axis is labeled with non-transformed values (pg/mL) for ease of interpretation. Change in IL-8 interacted with sex to predict change in HAM-D score (β = −0.63, p = 0.003). All analyses included age and BMI as covariates.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 50

Metadata

Authors
Kruse, J. L., Vasavada, M. M., Olmstead, R., Hellemann, G., Wade, B., Breen, E. C., Brooks, J. O., Congdon, E., Espinoza, R., Narr, K. L., & Irwin, M. R.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Kruse, Jennifer L.
Venue
Translational Psychiatry
Published
2021-03-15
Volume
11
Issue
1
Pages
167-167
ISSN
2158-3188 (ISSN-L)
OpenAlex
W3137344175
Cited by
48
References
51
Citations by year
2026: 7 · 2025: 9 · 2024: 9 · 2023: 10 · 2022: 10 · 2021: 3
FWCI
4.67
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH092301, K24MH102743, U01MH110008)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
depression, ketamine, interleukin-8, sex differences, treatment response, inflammation, inflammatory markers, antidepressant response, electroconvulsive therapy, personalized treatment
MeSH terms
Depression, Electroconvulsive Therapy, Female, Humans, Ketamine, Male, Psychiatric Status Rating Scales, Sex Factors, Interleukin-8, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Depression treatment response to ketamine: sex-specific role of interleukin-8, but not other inflammatory markers. https://app.cochat.ai/papers/10.1038/s41398-021-01268-z
The paper
Kruse, J. L., Vasavada, M. M., Olmstead, R., Hellemann, G., Wade, B., Breen, E. C., Brooks, J. O., Congdon, E., Espinoza, R., Narr, K. L., & Irwin, M. R. (2021). Depression treatment response to ketamine: sex-specific role of interleukin-8, but not other inflammatory markers. Translational Psychiatry. https://doi.org/10.1038/s41398-021-01268-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.